121 related articles for article (PubMed ID: 9787146)
1. Relationship between cleaved L-selectin levels and the outcome of acute myeloid leukemia.
Extermann M; Bacchi M; Monai N; Fopp M; Fey M; Tichelli A; Schapira M; Spertini O
Blood; 1998 Nov; 92(9):3115-22. PubMed ID: 9787146
[TBL] [Abstract][Full Text] [Related]
2. L and E selectins in acute myeloid leukemia: expression, clinical relevance and relation to patient outcome.
Aref S; Salama O; Al-Tonbary Y; Fouda M; Menessy A; El-Sherbiny M
Hematology; 2002 Apr; 7(2):83-7. PubMed ID: 12186696
[TBL] [Abstract][Full Text] [Related]
3. [Plasma concentration of the shed form of L-selectin (sL-selectin) in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) and its relation to the clinical course].
Kapelko-Slowik K; Jaźwiec B; Mirosław S; Wołowiec D; Urbaniak-Kujda D; Tomaszewska-Toporska B; Potoczek S; Ciszak L; Kuliczkowski K
Pol Arch Med Wewn; 2004 Nov; 112(5):1283-8. PubMed ID: 15773509
[TBL] [Abstract][Full Text] [Related]
4. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium.
Spertini O; Callegari P; Cordey AS; Hauert J; Joggi J; von Fliedner V; Schapira M
Blood; 1994 Aug; 84(4):1249-56. PubMed ID: 7519478
[TBL] [Abstract][Full Text] [Related]
5. Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Nuessler V; Schmetzer H
Eur J Haematol; 2003 Nov; 71(5):366-76. PubMed ID: 14667200
[TBL] [Abstract][Full Text] [Related]
6. [Study on expression of cell surface L-selectin and soluble L-selectin in patients with acute leukemia].
Chang JH; Qi ZH; Chen FP; Xie QZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):251-5. PubMed ID: 12844406
[TBL] [Abstract][Full Text] [Related]
7. Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.
Strupp C; Gattermann N; Giagounidis A; Aul C; Hildebrandt B; Haas R; Germing U
Leuk Res; 2003 May; 27(5):397-404. PubMed ID: 12620291
[TBL] [Abstract][Full Text] [Related]
8. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.
Kern W; Haferlach T; Schoch C; Loffler H; Gassmann W; Heinecke A; Sauerland MC; Berdel W; Buchner T; Hiddemann W
Blood; 2003 Jan; 101(1):64-70. PubMed ID: 12393605
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination.
Stucki A; Rivier AS; Gikic M; Monai N; Schapira M; Spertini O
Blood; 2001 Apr; 97(7):2121-9. PubMed ID: 11264180
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of the detection of the sL-selectin level in patients with acute leukemia].
Chang JH; Qi ZH; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):151-3. PubMed ID: 12575346
[TBL] [Abstract][Full Text] [Related]
11. Cleaved L-selectin concentrations in meningeal leukaemia.
Stucki A; Cordey AS; Monai N; de Flaugergues JC; Schapira M; Spertini O
Lancet; 1995 Feb; 345(8945):286-9. PubMed ID: 7530792
[TBL] [Abstract][Full Text] [Related]
12. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry.
Guerci A; Merlin JL; Missoum N; Feldmann L; Marchal S; Witz F; Rose C; Guerci O
Blood; 1995 Apr; 85(8):2147-53. PubMed ID: 7536492
[TBL] [Abstract][Full Text] [Related]
13. Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance.
Meckenstock G; Aul C; Hildebrandt B; Heyll A; Germing U; Wehmeier A; Giagounidis A; Suedhoff T; Burk M; Soehngen D; Schneider W
Leuk Lymphoma; 1998 May; 29(5-6):523-31. PubMed ID: 9643566
[TBL] [Abstract][Full Text] [Related]
14. Not the presence but the amount of clonal DNA detectable in remission of acute myeloid leukemia is predictive for relapse.
Reif SW; Wiesner D; Duell T; Mittermueller J; Schmetzer HM
Eur J Haematol; 2001 Oct; 67(4):207-20. PubMed ID: 11860441
[TBL] [Abstract][Full Text] [Related]
15. Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.
Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; Meijer J; van Oosterhoud S; van Putten WL; Valk PJ; Berna Beverloo H; Tenen DG; Löwenberg B; Delwel R
Hematol J; 2003; 4(1):31-40. PubMed ID: 12692518
[TBL] [Abstract][Full Text] [Related]
16. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
Tavernier E; Le QH; Elhamri M; Thomas X
Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia.
Li Q; Kopecky KJ; Mohan A; Willman CL; Appelbaum FR; Weick JK; Issa JP
Clin Cancer Res; 1999 May; 5(5):1077-84. PubMed ID: 10353741
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
[TBL] [Abstract][Full Text] [Related]
19. Anthracycline drugs and MDR expression in human leukemia.
Pogliani EM; Belotti D; Rivolta GF; Maffè PF; Corneo G
Cytotechnology; 1996; 19(3):229-35. PubMed ID: 8862011
[TBL] [Abstract][Full Text] [Related]
20. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
